Cytophage Technologies (TSXV:CYTO.H) Research & Development: C$0.19 Mil (TTM As of Dec. 2025)


What is Cytophage Technologies Research & Development?

Cytophage Technologies TSXV:CYTO.H Research & Development is C$0.19 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Cytophage Technologies's Research & Development for the three months ended in Dec. 2025 was C$0.06 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was C$0.19 Mil.

Cytophage Technologies  (TSXV:CYTO.H) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cytophage Technologies Research & Development Related Terms

Cytophage Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for Cytophage Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cytophage Technologies Research & Development Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
0.43 0.44 0.44 0.02 0.19

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.02 0.04 0.07 0.06

Cytophage Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of C$0.19 Mil mean?
Cytophage Technologies (TSXV:CYTO.H) has a Research & Development of C$0.19 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Cytophage Technologies and its competitors.
Is Cytophage Technologies' Research & Development too high?
Cytophage Technologies' current Research & Development is C$0.19 Mil.
How does Cytophage Technologies' Research & Development compare to VRTX and REGN?
Cytophage Technologies' Research & Development of C$0.19 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cytophage Technologies and its competitors. Cytophage Technologies's current Research & Development is C$0.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cytophage Technologies stock overvalued right now?
Cytophage Technologies (TSXV:CYTO.H) has a current Research & Development of C$0.19 Mil. The current Research & Development is C$0.19 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cytophage Technologies (TSXV:CYTO.H), the current Research & Development is C$0.19 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cytophage Technologies Business Description

Address 400 Fort Whyte Way, Suite 200A, Oak Bluff, MB, CAN, R4G 0B1
Cytophage Technologies Ltd is a Canadian biotechnology company engaged in the development of bacteriophages using molecular genetics and synthetic biology techniques. The company focuses on developing bacteriophage-based solutions to address bacterial challenges affecting animal health, human health, and food security, including antibiotic-resistant bacterial strains.